Stroke occurs in about 800,000 U.S. patients each year. Taylor Kimberly, MD, PhD, MGH, discusses his work running a phase 3 clinical trial investigating brain swelling in stroke patients and the challenges associated with running a multisite clinical trial.

Transcript: https://bit.ly/3qBPD7n

Stroke occurs in about 800,000 U.S. patients each year. Taylor Kimberly, MD, PhD, MGH, discusses his work running a phase 3 clinical trial investigating brain swelling in stroke patients and the challenges associated with running a multisite clinical trial. Transcript: https://bit.ly/3qBPD7n

Share Targeting Stroke in Phase 3 Trials

Sign up to save your podcasts

Targeting Stroke in Phase 3 Trials

Targeting Stroke in Phase 3 Trials